摘要:
A recombinant transfer vector capable of expressing a foreign gene fused to a viral gene under the control of dual promoters and a recombinant baculovirus, and methods for production thereof, as well as pharmaceuticals comprising the recombinant baculovirus as an active ingredient.
摘要:
Polynucleotides which are novel causative genes for cancer are elucidated, and a detection method of the polynucleotides or polypeptides encoded by the polynucleotides, and a kit and a primer set for detection are provided, based on the knowledge gained by the elucidation. In the detection method, a fusion gene comprising part of an SDC4, CD74, EZR, SLC34A2, LRIG3, or TPM3 gene and part of a ROS1 gene, or a fusion protein encoded by the fusion gene is detected. The primer set or the detection kit comprises a sense primer designed based on a portion encoding SDC4, CD74, EZR, SLC34A2, LRIG3, or TPM3 and an antisense primer designed based on a portion encoding ROS1.
摘要:
The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; and pharmaceuticals containing the recombinant baculovirus as an active ingredient.
摘要:
An object of the present invention is to provide a GLP-1 secretagogue which is an incretin hormone-related drug relatively inexpensive, excellent in safety, and capable of promoting GLP-1 secretion without containing sucrose as an essential constituent. The object is achieved by a GLP-1 secretagogue characterized by containing D-psicose as an active ingredient.
摘要:
Disclosed is a surgical system for small-pit closure in hollow organs having excellent operability, safety, and reliability, and whereby it is possible to reduce the duration and invasiveness of surgery by avoiding major surgical procedures. The surgical system is provided with a surgical device (1, 1A) for small-pit closure in hollow organs, with said surgical device including the following components, which are connected sequentially: a suture-member cartridge (5-5B) in which a pair of parallel tubular members (51) that accommodate respective suture members (100-120) configured of a suture thread (103-143) are feedably connected to the rear ends of a pair of arrowy-shaped members (101-121) that latch into tissue in a hollow organ; an auxiliary shooting unit (3-3B) having plungers respectively provided in a pair of cylinders (31, 31B) open at both ends; a hollow-organ-insertable unit (2, 2A) configured of a pair of flexible air tubes; and a gas shooter (4-4B) that sequentially discharges compressed air or high-pressure gas into the open-ended cylinders in response to operations of a trigger (44-4B4), for sequentially ejecting the arrowy-shaped members and driving the same into tissue in the hollow organ (T) on both sides of a small pit (Tc) site. The surgical device is used, in combination with an endoscope (200, 200A) that is inserted into the hollow organ, for closing and suturing the hollow organ tissue at the small-pit site.
摘要:
Provide a system and method for use in NOTES so as to reduce surgical invasiveness. An insertion body that is connected by an anvil assembly and joined to a thin wire guide (electric guide wire), is inserted via a natural orifice into a hollow organ so as to incise and remove a diseased or defective site from the hollow organ by using a pair of (front-end/rear-end) linear cutters of a linear cutting/stapling device (linear stapler), after which the two cut ends of the tract are anastomosed and recovered by a circular anastomosis surgical stapler that is equipped with the system.
摘要:
A recombinant transfer vector capable of expressing a foreign gene fused to a viral gene under the control of dual promoters and a recombinant baculovirus, and methods for production thereof, as well as pharmaceuticals comprising the recombinant baculovirus as an active ingredient.
摘要:
[Problem] The present invention provides a novel pathological marker of angiitis which serves as an alternative to MPO-ANCAs. [Means for Solution]According to one embodiment of the present invention, a method for testing angiitis which includes a step of detecting an antibody specifically recognizing a moesin in a biological sample is provided. In addition, according to another embodiment of the present invention, a reagent for testing angiitis which contains a substance that detects an antibody specifically recognizing a moesin in a biological sample is provided.